Name: UMIN ID:
Unique ID issued by UMIN | UMIN000019659 |
---|---|
Receipt number | R000022569 |
Scientific Title | A pilot study to evaluate efficacy and safety of sofosbuvir and daclatasvir for HCV genotype 3 infection in HIV and HCV co-infected hemophiliacs |
Date of disclosure of the study information | 2015/11/06 |
Last modified on | 2022/11/11 12:51:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/11/06 11:12:14 | ||
2 | Update | 2015/11/06 13:29:30 | Key inclusion criteria Key exclusion criteria |
|
3 | Update | 2015/11/06 13:31:01 | Organization Organization Organization Institute Organization Organization1 |
|
4 | Update | 2016/01/18 10:38:10 | Recruitment status |
|
5 | Update | 2017/04/18 16:31:38 | Recruitment status |
|
6 | Update | 2017/04/18 17:45:12 | Name of primary person or sponsor Organization |
|
7 | Update | 2021/05/14 11:47:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
8 | Update | 2022/11/11 12:45:43 | Recruitment status Date of IRB Last follow-up date |
|
9 | Update | 2022/11/11 12:50:51 | Last follow-up date |
|
10 | Update | 2022/11/11 12:51:22 | Publication of results Number of participants that the trial has enrolled |